Hybrid approach of ventricular assist device and autologous bone marrow stem cells implantation in end-stage ischemic heart failure enhances myocardial reperfusion

We challenge the hypothesis of enhanced myocardial reperfusion after implanting a left ventricular assist device together with bone marrow mononuclear stem cells in patients with end-stage ischemic cardiomyopathy. Irreversible myocardial loss observed in ischemic cardiomyopathy leads to progressive...

Descripción completa

Detalles Bibliográficos
Autores principales: Anastasiadis, Kyriakos, Antonitsis, Polychronis, Argiriadou, Helena, Koliakos, Georgios, Doumas, Argyrios, Khayat, Andre, Papakonstantinou, Christos, Westaby, Stephen
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034699/
https://www.ncbi.nlm.nih.gov/pubmed/21247486
http://dx.doi.org/10.1186/1479-5876-9-12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034699/
https://www.ncbi.nlm.nih.gov/pubmed/21247486
http://dx.doi.org/10.1186/1479-5876-9-12

Ejemplares similares